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Abstract 
Background: This study aimed to evaluate the effects of lycopene gel, as a natural antioxidant, 
mixed with a nanohydroxyapatite graft (NHG) covered by an occlusive resorbable collagen 
membrane (CM) in the surgical treatment of grade II furcation defects and on the gingival 
crevicular fluid (GCF) levels of 8-hydroxydeoxyguanosine (8-OHdG), as a marker of oxidative 
injury. Methods: In this randomized controlled clinical study a total of 24 patients with grade 
II furcation defects were randomly assigned into three equal groups. Furcation defects in group 
I were managed with lycopene gel mixed with NHG and CM, group II with NHG and CM, and 
group III with open flap debridement only. Site-specific changes in clinical parameters including 
probing depth (PD), vertical clinical attachment level (VCAL), horizontal clinical attachment 
level (HCAL), radiographic maximum vertical depth (MAX V), and maximum horizontal depth 
(MAX H) were measured at baseline and six months postoperatively. Gingival crevicular fluid 
levels of 8-OHdG were analyzed using enzyme-linked immunosorbent assay (ELISA) at baseline, 
one week, and three months. Results: Surgical management of grade II furcation defects 
resulted in a significant reduction in PD and 8-OHdG levels and a gain in CAL, MAX V, and MAX 
H in all groups. The differences between lycopene treated sites compared to NHG and CM alone 
were not significant at six months but demonstrated significantly superior clinical parameters 
compared to open flap debridement alone. Conclusion: Lycopene does not confer a benefit 
when combined with NHG in the surgical treatment of grade II furcation defects. 
Keywords: Furcation involvement; lycopene; nanohydroxyapatite; periodontal regeneration; 
8-hydroxydeoxyguanosine; collagen membrane
Introduction 
Periodontitis is an inflammatory condition 
affecting the gingiva, periodontal ligament, 
alveolar bone, and cementum.1 The primary 
causative factors for periodontitis are gram-
negative anaerobic or facultative anaerobic 
bacteria within the subgingival biofilm. 
Thus, periodontal therapy aims to remove 
bacteria using conventional periodontal 
pocket debridement (PPD). However, most 
of the periodontal tissue damage occurs due 
to the abnormal host response to pathogenic 
bacteria including overproduction of 
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reactive oxygen species (ROS) by host 
defense cells.2 The imbalance between ROS 
production and the antioxidant defense 
system might lead to the generation of 
oxidative stress, which plays an important 
role in the pathogenesis of periodontal 
disease.3,4 
The furcation area poses an 
additional challenge for the clinician to 
manage. This is because the unfavorable 
complex morphology and restricted-access 
area that characterizes furcation defects 
limit not only the efficacy of nonsurgical and 
surgical therapies, but also the patient’s self-
performed plaque control.5 The American 
Academy of Periodontology (AAP) 
concluded in its regeneration workshop on 
furcation defects that regeneration is a viable 
treatment option for molars with class II 
defects and recommended this approach to 
be considered before other treatments.6 
Markers such as 8-
hydroxydeoxyguanosine (8-OHdG), which 
correlates reliably with increased ROS 
production and activity during periodontal 
inflammation, can be used to evaluate the 
efficacy of antioxidants on oxidant stress.7 
An increase in 8-OHdG can be considered a 
sign of periodontal destruction and the 
subsequent post-treatment decrease in its 
levels has been well demonstrated in 
periodontitis, thus reflecting the status of 
periodontal health.8 
Lycopene is one of the most effective 
antioxidants found in red-colored fruits such 
as tomatoes and exhibits the highest 
quenching rate with singlet oxygen.9 
Lycopene scavenges a large spectrum of free 
radicals including superoxide, hydrogen 
peroxide, and hydroxyl radicals. Chandra et 
al. reported a significant improvement in 
patients with gingivitis and periodontitis 
following systemic oral administration of 
lycopene soft gels and the local application of 
lycopene gel as a monotherapy and as an 
adjunctive therapy along with PPD.10-12 
However, there is a lack of evidence to 
support the use of lycopene locally with 
periodontal surgery. 
 
a Random Allocation Software 2.0 
b Nanjing Zelang Medical Technology Co., Ltd., 
Nanjing, China 
Considering the previously 
mentioned properties of lycopene, we 
hypothesized that it would have a promising 
effect on the regeneration of furcation 
defects. To the best of the authors’ 
knowledge, this is the first study to clinically 
investigate the possible adjunctive use of 
lycopene in the surgical management of 
grade II furcation defects. The study also 
evaluated the antioxidant effect of lycopene 
through the measurement of gingival 
crevicular fluid (GCF) levels of 8-OHdG. 
Materials and Methods 
I. Patient Selection 
Thirty-two systemically healthy patients, 
based on a medical health questionnaire 
modified from Burket’s Oral Medicine, were 
selected from the outpatient clinic of the 
Periodontology Department of the Ain 
Shams University Faculty of Dental 
Medicine and the October 6 University 
Faculty of Dental Medicine.13 Subjects 
recruited in this 3-arm randomized 
controlled, assessor-blinded clinical trial 
had localized stage III grade B periodontitis 
according to the most recent AAP 
classification.14 
Periodontitis affected patients were 
randomly allocated using computer assessed 
randomizationa into three study groups of 
eight patients each. Group I included eight 
grade II furcation sites managed by open 
flap surgical debridement with lycopene gelb 
mixed with a nanohydroxyapatite graft 
(NHG)c covered by an occlusive resorbable 
collagen membraned and was considered the 
test group. Group II included eight grade II 
furcation sites managed by open flap 
surgical debridement with a placebo gel 
mixed with NHG covered by an occlusive 
resorbable collagen membrane and was 
considered the positive control group. Group 
III included eight grade II furcation sites 
managed only by open flap debridement and 
was considered the negative control group. 
The affected sites were selected for 
the study if grade II furcation involvement of 
the affected molar teeth evidenced 
c Nanostreams Company-NS0012, 6th of October 
City, Egypt 
d Hypro-Sorb® F, Bioimplon GmbH, Giessen, 
Germany 
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radiographically (using periapical 
radiographs for preliminary diagnosis) and 
clinically with a probing depth (PD) ≥4 mm, 
clinical attachment level (CAL) ≥5 mm, and 
horizontal probe penetration ≥3 mm one 
month following phase I periodontal 
therapy. Subjects with a history of 
periodontal surgery or administration of 
antimicrobial drugs or over the counter 
antioxidants within the three months prior 
to the baseline examination were excluded. 
In addition, subjects who reported any side 
effects or drug allergies from antioxidants 
and those with unacceptable oral hygiene 
upon re-evaluation of phase I therapy were 
also excluded. The study protocol was 
reviewed and approved by the research 
ethics committee of the Ain Shams 
University Faculty of Dental Medicine 
(FDASU-REC) in April 2016. Patients signed 
an informed consent and were permitted to 
withdraw at any time without penalty or loss 
of any benefits. The study protocol was 
registered and identified as NCT03203745 
at the U.S. National Institutes of Health 
Clinical Trials Registry. 
II. Interventions  
Initial cause-related therapy consisted of a 
single session of full mouth PPD performed 
at baseline using an ultrasonic scaling unite, 
a 4R-4L universal curette, and Gracey Mini 
Five curettesf until the root surface was 
clinically smooth and free of debris. 
Preparation of Lycopene Gel and Placebo 
Gel 
Lycopene was purchased in powder form (10 
gm) and was divided into 10 Eppendorf 
tubes, each containing 1 gm, and was 
microbiologically tested to ensure its safety 
(negative microbial test) and a heavy metal 
test was conducted (0.13%) to avoid taste 
changes. Lycopene gel was then dissolved in 
a solvent mixture of ethanol: propylene 
glycol: water in a ratio of 50:30:20. 
Triethanolamine was added to adjust the pH 
to above 7.4. The solution was gelled by 
adding 8% hydroxypropyl cellulose (HPC) 
and was set aside for 24 hours. The in situ gel 
was prepared to a concentration of 
approximately 2%. The lycopene gel was red 
 
e Woodpecker UDS-K LED Ultrasonic Scaler 
in color, odorless, and viscous for easy 
handling, manipulation, and adaptation of 
the mixture (gel and graft) to the defect. The 
placebo gel was prepared in the same 
manner without the active drug and it was 
transparent and odorless (Figures 1A and 
1B). 
Figure 1. 
A. Lycopene gel; B. Placebo gel 
III. Presurgical Procedure 
Presurgical Radiographic Measurements 
Prior to any clinical measurements, a cone 
beam computed tomography (CBCT) image 
of the site to be operated on was obtained. 
The radiographic maximum vertical depth 
(MAX V) was recorded in the sagittal view by 
measuring the distance from the furcation 
entrance to the base of the defect in the 
vertical direction (Figure 2).15 The 
radiographic maximum horizontal depth 
(MAX H) was recorded in the axial view by 
drawing a line from the most buccal end of 
one root to the other root followed by a 
perpendicular line from the center of the 
first line to the bone trabeculae start or crest 
(Figure 3).16  
Figure 2. 
Radiographic assessment of maximum vertical 
depth of the furcation (MAX V) 
f Hu-Friedy Mfg. Co., LLC, Chicago, IL, USA 
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Figure 3. 
Radiographic assessment of maximum 
horizontal depth of the furcation (MAX H) 
Presurgical Clinical Examination 
Baseline clinical parameters were recorded 
and included PD, plaque index (PI), gingival 
index (GI), vertical clinical attachment level 
(VCAL), and horizontal clinical attachment 
level (HCAL).17,18 The measurements were 
taken using the University of Michigan “O” 
probe with Williams markings and the 
Nabers probe.g Clinical parameters were 
documented on the day of the surgical 
procedure immediately prior to surgery 
(D.S.G.). 
Custom-made acrylic stents were 
fabricated to standardize the probe position 
and angulations (Figure 4). The occlusal 
stents were made with cold cure acrylic resin 
on a cast model obtained from an alginate 
impression and a groove was made in the 
stent in relation to each involved tooth. 
Probing depth was measured by subtracting 
the stent level (distance from the stent 
margin to the gingival margin) from the 
relative pocket depth (distance from the 
stent margin to the depth of the pocket).19 
The vertical clinical attachment level was 
measured by subtracting the distance from 
the stent margin to the cementoenamel 
junction (CEJ) from the relative pocket 
depth.19 The horizontal clinical attachment 
level was measured with a Nabers probe. The 
probe was penetrated until resistance was 
felt and the distance from the furcation 
entrance to the depth was recorded (Figure 
5).16 
GCF Collection and Enzyme-Linked 
Immunosorbent Assay (ELISA) 
 
g Hu-Friedy Mfg. Co., LLC, Chicago, IL, USA 
h WhatmanTM 
The site of the tooth was isolated with cotton 
rolls and a thin plaque film if present was 
removed manually using clean gauze.20 The 
site was then dried and the GCF was 
collected using filter paperh which was 
inserted into the depth of the pocket until 
minimal resistance was felt and was then left 
in the site for 30 seconds. The filter paper 
was subsequently removed from the pocket 
and inspected for any sign of contamination 
with either saliva or blood. Contaminated 
papers were discarded and the procedure 
was repeated after 30 minutes; otherwise, 
the samples were transferred to a pre-
weighed Eppendorf tube that contained 200 
ml of phosphate-buffered salinei and stored 
at -30°C till the time of processing.11 
Figure 4. 
Clinical vertical measurement using an acrylic 
stent; the red line is the CEJ, the white line is 
the gingival margin, the green line represents 
the stent margin, and the non-continuous line 
represents the base of the pocket. 
Figure 5. 
Clinical horizontal measurement of furcation 
using Nabers probe 
IV. Surgical Phase 
Following administration of local anesthesia 
and after rinsing with 0.12% chlorhexidine 
i Euroclone®, Milan, Italy 
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gluconatej a mucoperiosteal flap was 
reflected and thorough debridement was 
carried out (Figure 6A). The 
nanohydroxyapatite graft and resorbable 
collagen membrane were incorporated into 
the clean site either with lycopene gel in 
group I or with a placebo in group II and only 
open flap debridement was carried out in 
group III (Figures 6B and 6C). The flap was 
coronally advanced and secured with direct 
interrupted sutures to obtain primary 
closure with polypropylene monofilament, 
non-absorbable suturesk (Figure 6D). 
V. Postsurgical 
Patients were instructed to not brush the 
surgical site for a period of three weeks and 
to instead gently wipe the area with a cotton 
pellet dampened with saline and to rinse 
with 0.12% chlorhexidine gluconate twice 
daily for a period of three weeks starting 24 
hours postoperatively. Postoperative 
medications including amoxicillin 
clavulanate 1 gm (one capsule every 12 hours 
for five days) and ibuprofen 600 mg (one 
tablet three times daily after meals for four 
days) were prescribed.16 Sutures were 
removed ten days postoperatively. All 
clinical parameters were recorded again six 
months postoperatively and all radiographic 
parameters were again recorded nine 
months postoperatively. Patients were 
recalled after one week and three months to 
collect GCF samples for biochemical analysis 
in order to evaluate the levels of 8-OHdG 
which was used as a biomarker. 
VI. Statistical Analysis 
Based on a study conducted by Chandra et 
al., sample size was estimated assuming 
alpha error = 5% and study power = 80% 
and assuming effect size = 1.09 on 
comparing means of clinical attachment loss 
between the study and control group.12 The 
minimum sample size was calculated, using 
computer software,l to be seven per group 
which was increased to eight assuming 
dropouts.  All data were collected, tabulated, 
and statistically analyzed using computer 
software.m The difference between the two 
groups was statistically analyzed using an 
independent sample with the Student’s t-test 
and paired t-test. The F value of an analysis 
of variance (ANOVA) was calculated to 
compare between the three groups. All levels 
of significance were set at P<0.05.
Figure 6. 
Surgical steps: A. Furcation site after complete debridement; B. NHA graft placed into the furcation 
defect; C. Adaptation of collagen membrane over the furcation defect; D. Sutured flap
Results 
The study included nine males and 15 
females, with an age range from 34-54 years 
(mean age: 43 ±6.4 years). At baseline, there 
was no statistically significant difference 
between the three groups with regards to PD, 
VCAL, HCAL, MAX V, and MAX H mean 
values. At six months, there was a reduction 
in all clinical and radiographic parameters 
which was statistically significant in each 
 
j Hexitol 0.12%, Arab Drug Company (ADCO), Cairo, 
Egypt 
k Prolene®, 4-0, 5-0, Ethicon, Raritan, NJ, USA 
group. By comparing the three groups to 
each other, mean PD, VCAL, HCAL, MAX V, 
and MAX H for groups I and II at six months 
did not show a statistically significant 
difference, although group III’s parameters 
were significantly greater than group I and 
group II. Furthermore, significant 
reductions in furcation depths were 
demonstrated horizontally by 1.69 0.41 mm 
in group I, 1.73 0.48 mm in group II, and 
0.64 0.66 mm in group III, and vertically by 
l G*Power 3.1.9.7, Heinrich Heine University 
Düsseldorf, Düsseldorf, Germany 
m IBM SPSS Statistics 21, Armonk, New York, USA 
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1.11 0.34 mm in group I, 1.25 0.37 mm in 
group II, and 0.62 0.54 mm in group III 
(Table 1). Biochemical analysis revealed that 
there was no statistically significant 
difference between the three groups with 
regards to the mean value of 8-OHdG, which 
decreased significantly in all groups (Table 
2).
Table 1: ANOVA and mean changes in PD, VCAL, HCAL, MAX V, and MAX H in different 
treatment groups (mean SD) 



































































Significance level: *P<0.05, **P<0.01, ***P<0.001; ns: non-significant; similar superscripts in same row 
are indicative of non-significant differences 






Significance level: ***P<0.001; ns: non-significant
Discussion 
In the present study, the reduction in 
oxidative stress was reflected by a decrease 
in PD and CAL. The results of the current 
study are in agreement with multiple studies 
that evaluated oxidative stress in 
periodontally diseased individuals and with 
studies that evaluated the efficacy of locally 
delivered lycopene gel in chronic 
periodontitis.4,11,12,21-22 In our study, 
postoperative follow-up at six months 
showed a significant reduction in PD and 
CAL in all treatment groups and these 
findings were in accordance with the 
outcomes of several studies.11,12,23 Thus, we 
concluded that a reduction in PD and CAL 
can be obtained through appropriate 
PPD.24,25 In the present study, lycopene 
treated sites compared to open flap 
debridement alone showed a significant 
reduction in PD and CAL which was in 
agreement with several studies that 
evaluated lycopene locally.11,12,23 
Some studies that evaluated lycopene 
systemically, showed nonsignificant results 
when compared to the placebo group which 
was not in agreement with the previously 
mentioned studies.26,27 Our explanation for 
the nonsignificant differences witnessed in 
our study with regards to the lycopene and 
placebo groups, is that lycopene exerts its 
maximum effect during the first week with a 
gradual decrease in its therapeutic action for 
a period of three months.12 As the initial 
reduction in oxidative injury can be 
considered a critical contributor towards the 
reduction in PD and CAL, and lycopene’s 
effect on oxidative injury decreases with 
time, its beneficial effects on clinical 
parameters are ultimately negated. Thus, 2% 
lycopene gel can be employed for controlled 
local delivery for only seven days in 
subgingival areas11. In addition, pro-oxidant 
agents generally show a rebound effect in 
their activity after suppression by 
antioxidants which might have also caused 
this trend toward a rising 8-OHdG.10,11 The 
 












Base Line 23.052.29 22.631.55 21.921.83 0.705 ns 
1 Week 11.961.41 13.161.36 12.862.14 1.108 ns 
3 Months 12.581.06 11.231.38 11.111.97 2.306 ns 
P-Value 0.000*** 0.000*** 0.000***  
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second explanation is that the regenerative 
technique, which included NHG and a 
collagen membrane, plays a role in PD and 
CAL reduction, as well as a decrease in the 
vertical and horizontal furcation 
components rendering the effect of lycopene 
insignificant, which was in accordance with 
other studies.28,29 
Only three studies have assayed 8-
OHdG levels directly from the GCF.11,12,30 In 
this study, all groups showed a highly 
significant reduction in GCF levels of 8-
OHdG from baseline to the end of the assay 
period and the results are in agreement with 
all previous studies in which periodontal 
treatment with or without lycopene therapy 
has been associated with a decrease in 8-
OHdG levels. This could be due to the effect 
of scaling and root planning, which has been 
shown to contribute to a reduction in 
oxidative stress, as was demonstrated in a 
study that evaluated an NHG with collagen 
membrane treated group in relation to a 
xenograft and membrane group in 
periodontal regeneration.21,28,31 Our results 
are also in accordance with a study that 
showed 2 mm of vertical furcation bone fill 
and 2 mm of vertical PD reduction after 
using anorganic bovine bone xenograft with 
a resorbable membrane, and yet another 
study that reported that nanocrystalline 
hydroxyapatite bone graft substitute in the 
treatment of intra-bony periodontal defects 
showed more reduction in PD when 
compared with the control group.32,33 
To summarize, as the addition of 
lycopene to NHG covered with a resorbable 
collagen membrane did not significantly 
improve clinical parameters compared to the 
placebo group, we concluded that lycopene 
does not confer a benefit when combined 
with NHG in the surgical treatment of grade 
II furcation defects. 
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